View of Patient Profiling and Outcome Assessment of Vildagliptin and Dapagliflozin FDC in Persons with Type 2 Diabetes Mellitus

Return to Article Details Patient Profiling and Outcome Assessment of Vildagliptin and Dapagliflozin FDC in Persons with Type 2 Diabetes Mellitus Download Download PDF